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Heme oxygenase-1 promotes neuron
survival through down-regulation of
neuronal NLRP1 expression after spinal
cord injury
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Abstract
Background: Understanding the mechanisms underlying neuronal death in spinal cord injury (SCI) and developing
novel therapeutic approaches for SCI-induced damage are critical for functional recovery. Here we investigated the
role of heme oxygenase-1 (HO-1) in neuroprotection after SCI.
Methods: Adeno-associated virus expressing HO-1 was prepared and injected into rat spinal cords before SCI
model was performed. HO-1 expression, inflammasome activation, and the presence of inflammatory cytokines
were determined by quantitative polymerase chain reaction, immunohistological staining, immunoblot, and
immunoprecipitation. Neuronal apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end
labeling. The hindlimb locomotor function was evaluated for extent of neurologic damage. In an in vitro model,
hydrogen peroxide was used to induce similar inflammasome activation in cultured primary spinal cord neurons,
followed by evaluation of above parameters with or without transduction of HO-1-expressing adeno-associated virus.
Results: Endogenous HO-1 expression was found in spinal cord neurons after SCI in vivo, in association with the
expression of Nod-like receptor protein 1 (NLRP1) and the formation of NLRP1 inflammasomes. Administration of
HO-1-expressing adeno-associated virus effectively decreased expression of NLRP1, therefore alleviating NLRP1
inflammasome-induced neuronal death and improving functional recovery. In the in vitro model, exogenous HO-1
expression protected neurons from hydrogen peroxide-induced neuronal death by inhibiting NLRP1 expression. In
addition, HO-1 inhibited expression of activating transcription factor 4 (ATF4), which is a transcription factor regulating
NLRP1 expression.
Conclusions: HO-1 protects spinal cord neurons after SCI through inhibiting NLRP1 inflammasome formation.
Background
Spinal cord injury (SCI) leads to complex cellular and
molecular interactions within the central nervous system
(CNS) in an attempt to repair the initial tissue damage.
The pathophysiology of SCI is characterized by the
shearing of cell membranes and axons, disruption of the
blood–spinal cord barrier, cell death, immune cell
transmigration, and myelin degradation [1]. There are
two mechanisms of damage to the spinal cord after in-
jury: the primary mechanical injury and the secondary
injury mediated by multiple injury processes [2]. SCI-
induced neuronal death in the lesion area seems to be
the consequence of both the primary injury and the sec-
ondary injury depending on its localization and temporal
process [3, 4]. Several molecular biological processes, in-
cluding changes of cell cycle-related gene expression,
endoplasmic reticulum (ER) stress, glutamate excitotoxi-
city, free radical production, and inflammatory cytokine
release contribute to neuronal death [1, 5–8]. Recently,
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inflammasome-associated neuronal programmed cell
death, termed pyroptosis, has been shown to contribute to
neuronal death in distinct neurological diseases [9–12].
Pyroptosis is induced by inflammasomes which consist of
an apoptosis-associated speck-like protein containing a
caspase recruitment domain (ASC), an adaptor protein,
and caspase-1, an inflammatory cysteine–aspartic protease
[13, 14]. The formation of inflammasomes activates
caspase-1 and subsequently leads to plasma-membrane
pore formation and cleavage of chromosomal DNA.
Caspase-1 dependence is a defining feature of pyroptosis,
and caspase-1 is the enzyme that mediates this process of
cell death [15]. In addition, caspase-1, also known as
interleukin-1-converting enzyme, plays an important role
in the inflammatory processes by cleaving pro-IL-1β into
mature pro-inflammatory IL-1β [16]. IL-1β can be pro-
duced and released by CNS neurons following distinct
stimulation and insults, suggesting that neurons are also a
source of neuroinflammation [9, 17–20]. Inflammasome
activation and formation have been shown to be present
in the CNS cells including spinal cord neurons after CNS
injury. For example, CNS trauma promotes the expression
of the NOD-like receptor protein-1 (NLRP1), ASC, and
caspase-1 in spinal cord motor neurons and cortical
neurons [21]. NLRP1 inflammasome formation occurs in
neurons after stroke in rodents [19]. NLRP1 inflamma-
somes are activated in patients with medial temporal lobe
epilepsy and contribute to neuronal pyroptosis in the
amygdala kindling-induced rat model [12]. Therefore, in-
hibition of inflammasome-mediated neuronal death could
be neuroprotective in several neurological disorders.
Heme oxygenases (HO) are evolutionarily conserved
enzymes that catabolize heme into equimolar amounts of
labile Fe, carbon monoxide, and biliverdin [22]. HO have
two types: HO-1 expression is induced ubiquitously in re-
sponse to various stresses, whereas HO-2 is constitutively
expressed and can be further induced by opioids and gluco-
corticoids [23–27]. HO and its by-product carbon monox-
ide were found to blunt the stress axis activation secondary
to many stimuli including immune-inflammatory stressors
[28–30]. A previous study showed that both HO-1 messen-
ger RNA (mRNA) and protein are elevated in the ventral
horn motor neurons shortly after experimental SCI [31]. In
addition, HO-1 modulates the secondary injury process,
and high HO-1 expression may preserve spinal cord func-
tion in the early stages after SCI [32]. Moreover, HO-1 sta-
bilizes the blood–spinal cord barrier and limits oxidative
stress and white matter damage in acutely injured murine
spinal cord [33]. Therefore, induction of HO-1 expression
could be a therapeutic approach for SCI. However, the
relationship between HO-1 and inflammasome-mediated
neuronal death has not been studied in SCI.
In this study, we examined the neuroprotective role of
HO-1 in SCI and explored the feasibility of using HO-1-
expressing adeno-associated virus (AAV) as a thera-
peutic approach for alleviating neuronal death in the
acute phase of SCI. We found that NLRP1 inflamma-
somes were assembled and activated in neurons in the
injury region after SCI. HO-1 expression was also in-
duced in neurons at the same region shortly after SCI.
In an in vitro model, we found that exogenous HO-1 ex-
pression protected neurons from NLRP1 inflammasome-
mediated neuronal death by inhibiting NLRP1 expression,
conversely silencing endogenous HO-1 expression with
small interfering RNA (siRNA) increased neuronal death.
In addition, HO-1 inhibited expression of activating tran-
scription factor 4 (ATF4), which is a transcription factor
regulating NLRP1 expression. Moreover, administration of
HO-1-expressing AAV into the spinal cord before SCI ef-
fectively decreased the expression of ATF4 and NLRP1
after SCI, therefore alleviating neuronal death and improv-
ing functional recovery. Taken together, our study indi-
cated that HO-1 protects spinal cord neurons through
inhibition of NLRP1 inflammasome formation.
Methods
Animals and SCI model
Adult male Sprague–Dawley rats (280–320 g) were used
in this study. The animal experiments were performed
in accordance with the guidelines of Laboratory Animals
and were approved by the Animal Care and Use Com-
mittee of Fujian Medical University. Spinal cord com-
pression at T12 was performed following an established
static compression model [34]. Briefly, animals were
anesthetized by inhalation of 2–3 % isoflurane adminis-
tered at a flow rate of 1 L/min. Midline skin incisions
were performed to expose the T12 spinous processes. A
laminectomy was performed at T12. The compression
was applied by suspending the base of a compression
platform (area 2 × 5 mm2) onto the exposed cord. A
weight of 50 g was applied statically to the platform for
exactly 5 min. After removing the platform, the muscles
and skins were sutured. In the sham group, only a
laminectomy was performed.
Primary spinal cord neuron culture and H2O2 treatment
Primary spinal cord neuron culture was conducted fol-
lowing the established method with minor modifications
[35, 36]. Briefly, spinal cords were dissected from E16
rat embryos. Isolated spinal cords free of meninges and
dorsal root ganglia were digested with 0.25 % Trypsin in
Hank’s balanced salt solution (HBSS, Hyclone) at 37 °C
for 30 min. The cell suspension was titrated in Dulbec-
co’s Modified Eagle Medium (DMEM) supplemented
with 1 % penicillin–streptomycin and 10 % fetal bovine
serum (FBS, Hyclone). Then 8 × 105 cells, 4 × 105 cells,
or 1 × 105 cells were seeded into each well of poly-L-
lysine-coated 6-well plates, 24-well plates, or 96-well
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plates, respectively. To treat primary neurons, H2O2
(Sigma-Aldrich) was added into the neuron culture at
the final concentration of 10 μM.
Preparation of adeno-associated virus
To produce AAV expressing HO-1 (termed A-HO-1
thereafter), HO-1 complementary DNA (cDNA) was
amplified by PCR and inserted to BamHI sites of pAAV-
CMV-EGFP and confirmed by sequencing. The recom-
binant plasmid was then packaged into AAV2/8 particles
(AAV2 ITRs; AAV8 capsid). All these procedures were
conducted by Neuronbiotech Company. The A-HO-1
titer was 5.5 × 1012 genome copies/ml, and the titer of
EGFP-expression control AAV2/8 virus (termed A-C
hereafter) was 7.5 × 1012 genome copies/ml. Viral titer
was determined with quantitative PCR by the detection
of WPRE element copies of AAV genome.
AAV administration in vitro and in vivo
To transduce primary neurons, on day 7 in vitro, 2.0 ×
1011 genome copies of AAV in 50 μl of PBS were added
into each well of six-well plates containing 1.5 × 105 cells
in 1.5 ml medium and were incubated for 24 h before
further processing or treatment.
To assess the effect of A-HO-1 in vivo, the rats were
randomly assigned to three groups including vehicle, A-
C and the A-HO-1 groups. Seven days before SCI, 3 μl
of normal saline was injected into the spinal cord of the
vehicle group rats at T12 at a rate of 0.2 μl/min using a
5-μl micro-syringe with a 33-gauge needle (Hamilton).
At the same time point using the same method, 3 μl of
A-C or A-HO-1 was injected into the rats of A-C group
or A-HO-1 group, respectively. After injection, the injec-
tors were removed and the muscles and skins were su-
tured in separate layers.
siRNA transfection
siRNAs for HO-1, NLRP1, and ATF4 were purchased
from Santa Cruz Biotechnolgy. siRNAs (50 pmol each)
were transfected into 1.5 × 105 primary neurons using
RNAiMAX reagent (Life Technologies) according to
manufacturer’s protocol. After 24 h, cells were subject to
further processing including immunoblot and H2O2
treatment.
Immunofluorescent staining
The spinal cord was fixed with 4 % paraformaldehyde
and then was embedded in paraffin using a Leica
APS300. Five-micron cross sections were prepared, and
antigen retrieval was performed by boiling sections in
sodium citrate buffer (10 mM sodium citrate, 0.05 %
Tween 20, pH 6.0) for 30 min. Anti-NLRP1 (Abcam),
anti-HO-1 (Santa Cruz Biotechnology), and anti-MAP2
(Millipore) antibody were used for staining according to
the manufacturer’s instructions. Alexa Fluor 488 donkey
anti-rabbit IgG and Alexa Fluor 594 chicken anti-goat
IgG (both from Invitrogen) were used as secondary anti-
bodies. The sections were observed on a Leica DMIRE2
inverted fluorescent microscope.
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL)
Primary neuron culture or spinal cord sections were la-
beled with DeadEnd™ Fluorometric TUNEL System
(Promega) following the manufacturer’s manual. The
sections were observed on a Leica DMIRE2 inverted
fluorescent microscope.
RNA isolation, reverse transcription, and quantitative
RT-PCR (q-RTPCR)
Total RNA was extracted from cells or tissues using the
RNeasy Mini Kit (Qiagen). cDNA synthesis was performed
using SuperScript® III First-Strand Synthesis System (Invi-
trogen). q-RTPCR was performed using Fast SYBR® Green
Master Mix (Invitrogen) on a 7300 q-RTPCR System
(Invitrogen). Data was analyzed with 7300 system software
(Invitrogen). Primer sequences for each gene are as follows:




TG-3′) and (5′-GCCACAGGGATTTTGTCGTT-3′). NLR









CA-3′) and (5′-GCTGGTATCGAGGAATGTGC-3′). PCR
conditions used for all primer sets were as follows: 95 °C
hot start for 10 min, followed by 40 amplification cycles of
95 °C for 15 s (denaturing), 60 °C for 1 min (annealing, ex-
tension, and detection). Relative abundance of RNA was
analyzed using 2−ΔΔCt method.
Immunoblot assay
The following antibodies were used for immunoblot:
anti-β-actin, anti-ASC, anti-HO-1, anti-HO-2, anti-
ATF4, and anti-CHOP antibodies were purchased from
Cell Signaling Technology. Anti-NLRP1, anti-NLRP3,
anti-NLRC4, anti-AIM2, and anti-pro-caspase-1 anti-
bodies were purchased from Abcam. Anti-caspase-1
antibody (against both pro-caspase-1 and p20) was
purchased from Santa Cruz Biotechnology. Anti-IL-1β
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(against both pro-IL-1β and mature IL-1β) was pur-
chased from Novus Biologicals.
Co-immunoprecipitation
To assess the formation of NLRP1 inflammasome, spinal
cord tissues or cultured neurons were lysed in 50 mM
Tris-HCl (pH 7.4), 150 mM NaCl, 0.5 % NP-40, and
complete protease inhibitors (Roche). Five hundred mi-
crograms of spinal cord lysates from sham or SCI ani-
mals, or primary neuron homogenates, were incubated
on ice for 15 min and then centrifuged at 2600×g for
5 min at 4 °C to remove tissue/cell debris. Immunopre-
cipitation assays were performed using 1 mg magnetic
Dynabeads (Invitrogen) coupled to 7 mg of anti-NLRP1
(Abcam) or anti-ASC (Cell Signaling Technology) anti-
body according to the manufacturer’s instructions.
Briefly, 250 μg of lysate applied to 1.5 mg of anti-NLRP1
or anti-ASC antibody-coupled magnetic beads, incu-
bated overnight at 4 °C on a rotator, and eluted in a low
pH buffer. Pre-immune serum (Abnova) served as a
negative control. Elutions were collected and added to
×1 Laemmli buffer to dissociate proteins. Five microli-
ters of 1 M Tris (pH 9.8) were added to match the pH
of the stacking gel. Samples were then boiled for 5 min
and subjected to SDS-PAGE and immunoblot analysis
with indicated antibodies.
Neurologic evaluation
The hindlimb locomotor function was assessed at pre-
injury and 1, 3, 7, 14, and 21 days after SCI using the
BBB locomotor test developed by Basso et al. [37]. The
hindlimb movements during locomotion were quantified
using a scale ranging from 0 to 21. The rats were ob-
served for 5 min at each time point by two observers
who were blinded to the experimental protocol.
Statistics
Data was presented as mean ± SD and analyzed by statis-
tical software (Prism 6.0, GraphPad Software). Student’s
t test or one-way ANOVA was used for comparison of
mean between the groups. For BBB score analysis,
repeated-measures ANOVA was used. p values <0.05
were considered significant.
Results
SCI induces expression of inflammasome components
The activation of inflammasome pathways in neuro-
logical disorders including SCI has been documented
previously [38]. To investigate the temporal dynamics
and types of inflammasomes after SCI, we firstly deter-
mined mRNA levels of different inflammasome compo-
nents in the injury region at different time points after
SCI. We found that NLRP1 mRNA was significantly ele-
vated from 18 to 24 h after SCI. NLRP3 mRNA was
slightly up-regulated at 6 h but returned to basal level at
18 h. There was not significant change of NLRC4 mRNA
level. Caspase-1 mRNA and ASC mRNA were also up-
regulated after SCI (Fig. 1a). Immunoblot showed consist-
ent increases in the protein levels of NLRP1, caspase-1,
and ASC (Fig. 1b, c). However, protein levels of NLRP3
and NLRC4 were not significantly altered (Fig. 1b). The
increase of NLRP1 expression was confirmed by histo-
logical staining, and it seemed that neurons express
NLRP1 (Fig. 1d). The expression of pro-inflammatory cy-
tokines IL-1β and TNF-α was also increased at 6 h after
SCI and remained at high levels until 24 h (Fig. 1e).
SCI induces NLRP1 inflammasome activation
To determine whether NLRP1 inflammasomes are
formed after SCI, the processing of pro-caspase-1 and
pro-IL-1β was tested. SCI induced significant increases
in both pro-caspase-1 and caspase-1 p20 levels, suggest-
ing that pro-caspase-1 was substantially cleaved to be-
come activated caspase-1 by inflammasome formation
(Fig. 2a). Consistently, mature IL-1β level was also up-
regulated after SCI, suggesting that activated caspase-1
cleaved pro-IL-1β into mature IL-1β (Fig. 2b). To
characterize the association of inflammasome proteins
after SCI, co-immunoprecipitations of post-SCI spinal
cord lysates were performed using anti-ASC antibody,
anti-NLRP1 antibody, and pre-immune serum, respect-
ively. As shown in Fig. 2c, in the sham spinal cord, ASC
was immunoprecipitated with anti-ASC antibody, and
low levels of NLRP1 and caspase-1 were present in this
signaling complex. At 24 h after SCI, there was increased
association of NLRP1 and caspase-1with ASC. In
addition, the pro-caspase-1 associated to ASC was
cleaved to generate activated caspase-1, demonstrated by
increased immunoprecipitated caspase-1 p20. Consist-
ently, immunoprecipitation with anti-NLRP1 antibody
showed increased association of ASC and pro-caspase-1
with NLRP1, in comparison with the sham control. As a
negative control, pre-immune serum did not immuno-
precipitate the inflammasome-associated proteins, indi-
cating the antibody specificity. Taken together, our data
suggested that SCI not only induced expression of
NLRP1 inflammasome components but also triggered
the assembly of inflammasomes.
SCI induces HO-1 expression in spinal cord neurons
HO-1 has been shown to be induced after SCI [31]. To
confirm this, we examined expression of HO-1 in the
SCI region. As shown in Fig. 3a, b, HO-1 protein level
was relatively low immediately after SCI and was not
changed at 6 h after SCI. However, at 18 h after SCI, its
expression was remarkably up-regulated and stayed high
until 24 h. Immunofluorescent staining revealed en-
hanced HO-1 expression in MAP2+ neurons, suggesting
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that SCI induced HO-1 expression in spinal cord neu-
rons (Fig. 3c).
HO-1 inhibits NLRP1 expression to alleviate neuronal
death induced by hydrogen peroxide
To investigate the effect of HO-1 on neuronal survival,
we employed an in vitro model using H2O2 to induce
neuronal damage. Primary spinal neurons were treated
with H2O2 for 6 h, and inflammasome signaling was
evaluated. Similar to SCI, H2O2 induced a significant in-
crease in NLRP1 expression compared with untreated
control, while expression of AIM2, NLRP3, and NLRC4
was not changed (Fig. 4a). Co-immunoprecipitation indi-
cated that the association of ASC and pro-caspase-1
with NLRP1 was weak in untreated neurons, whereas
H2O2 promoted the association of NLRP1 with ASC and
pro-caspase-1, suggesting enhanced formation of NLRP1
inflammasomes (Fig. 4b). Of note, in H2O2-treated
neurons, NLRP1-associated caspase-1 p20 was also
higher than that in untreated neurons, suggesting
caspase-1 activation in H2O2-treated neurons (Fig. 4b).
Therefore, H2O2 triggered a pattern of inflammasome
activation similar to SCI and presented a viable in vitro
model to simulate SCI-induced inflammasome activa-
tion. We then manipulated the expression of HO-1 in
this model by transfection of HO-1 siRNA or transduc-
tion of HO-1-expressing AAV (A-HO-1) into primary
spinal neurons. In our preliminary study, HO-1 siRNA
inhibited HO-1 expression while not altering HO-2
(Additional file 1: Figure S1A). Transduction of control
AAV (A-C) did not significantly change the expression
of HO-1 and NLRP1 (Additional file 1: Figure S1B),
suggesting that AAV transduction procedure cannot
alter HO-1 and NLRP1 expression. In addition, neither
transfection of scramble siRNA nor transduction of
control AAV triggered caspase-1 activation, suggesting
Fig. 1 SCI induces expression of inflammasome components in the spinal cord. a mRNA levels of inflammasome components in injured spinal
cords were determined by q-RTPCR at different time points after SCI. b Protein levels of inflammasome components in injured spinal cords were
determined by immunoblot at different time points after SCI. c Statistical analysis for protein levels of inflammasome components in injured spinal
cords after SCI. d Immunofluorescent staining of NLRP1 in spinal cords. e mRNA levels of IL-1β and TNF-α in the injured spinal cords were determined by
q-RTPCR at different time points after SCI. 0: immediately after SCI. N= 6 per group. *p< 0.05; **p< 0.01; ***p< 0.001 in comparison with the “0” group
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that inflammasome formation was not induced by
the transfection or transduction procedures themselves
(Additional file 1: Figure S1C). After H2O2 treatment,
compared with vehicle control, A-HO-1 significantly
increased HO-1 expression while down-regulating
NLRP1 expression (Fig. 4c, d). Conversely, HO-1
siRNA reduced HO-1 expression while up-regulating
NLRP1 level (Fig. 4c, d). This data suggested that HO-1
negatively regulated NLRP1 expression in H2O2-treated
neurons. Consistent with the change of NLRP1 expres-
sion, A-HO-1 significantly reduced caspase-1 activa-
tion, demonstrated by lower level of caspase-1 p20
when compared to vehicle control (Fig. 4e). HO-1
siRNA remarkably increased caspase-1 p20 level
(Fig. 4e), suggesting that HO-1 inhibited NLRP1
expression and subsequently decreased NLRP1
inflammasome-induced caspase-1 activation.
To investigate whether NLRP1 expression was related
to neuronal death, we transfected primary neurons with
NLRP1 siRNA before H2O2 treatment. NLRP1 siRNA ef-
fectively decreased NLRP1 expression and did not influ-
ence the expression of NLRP3 and NLRC4 (Additional
file 1: Figure S1D and S1E). Neuronal death was evalu-
ated by TUNEL at 12 h after H2O2 treatment. We found
that H2O2 induced substantial TUNEL-positive cells,
while A-HO-1 decreased TUNEL-positive cells, and
HO-1 siRNA robustly increased TUNEL-positive cells
(Fig. 4f, g). NLRP1 siRNA also significantly reduced
TUNEL-positive cells after H2O2 treatment (Fig. 4f, g).
Scramble siRNA transfection and control AAV
Fig. 2 NLRP1 inflammasomes are formed in the spinal cord after SCI. a Expression of pro-caspase-1 and caspase-1 p20 in injured spinal cords after
SCI. Left panel: representative immunoblot image. Right panel: statistical analysis for caspase-1 p20. 0: immediately after SCI. b Expression of pro-IL-
1β and mature IL-1β in injured spinal cords after SCI. Left panel: representative immunoblot image. Right panel: statistical analysis for mature IL-1β.
0: immediately after SCI. c Association of ASC, NLRP1, and caspase-1 in injured spinal cords was determined by co-immunoprecipitation.
N = 6 per group. ***p < 0.001 in comparison with the “0” group
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transduction did not significantly altered TUNEL stain-
ing (Additional file 1: Figure S2). Thus, our data indi-
cated that NLRP1 induced neuronal death and HO-1
inhibited neuronal death through inhibiting NLRP1
expression.
HO-1 regulates NLRP1 expression through ATF4
A recent study indicates that transcription factor ATF4
induces NLRP1 expression during ER stress [39]. In
addition, ER stress contributes to cell death and survival
in a SCI model [40]. Therefore, we tested whether HO-1
could regulate NLRP1 expression via ATF4. We firstly
checked the expression of ATF4 and its target C/EBP
homology protein (CHOP) in H2O2-treated primary
spinal cord neurons. H2O2 significantly up-regulated
ATF4 and CHOP levels (Fig. 5a). To evaluate the role of
ATF4 in regulating NLRP1 expression, we transfected
primary spinal cord neurons with different concentra-
tions of ATF4 siRNA before H2O2 treatment. As shown
in Fig. 5b, the ATF4 mRNA level was decreased by
ATF4 siRNA in a dose-dependent manner. Of note, the
NLRP1 mRNA level was also decreased in association
with the decrease of ATF4 mRNA, suggesting that ATF4
positively regulated NLRP1 expression. To investigate
the role of ATF4 in H2O2-induced neuronal death,
TUNEL was performed. We found that ATF4 siRNA
inhibited neuronal death in a dose-dependent manner
(Fig. 5c). We then evaluated the effect of exogenous
HO-1 on ATF4 expression by transducing neurons with
A-HO-1. When compared to non-transduced control
cells, A-HO-1 significantly reduced ATF4 protein level
(Fig. 5d) and mRNA level (Fig. 5e). To exclude the possi-
bility that AAV transduction itself influences ATF4 ex-
pression, A-C was transduced into both untreated and
H2O2-treated neurons. We found insignificant changes
in ATF4 mRNA level between transduced and non-
transduced neurons, suggesting AAV itself did not alter
ATF4 expression (Additional file 1: Figure S3). There-
fore, the change in A-HO-1-transfected neurons should
be ascribed to the effect of HO-1.
HO-1 protects neurons from SCI in vivo
Similar to in vitro H2O2 treatment, SCI induced up-
regulation of ATF4 and CHOP in the injury region of
spinal cord (Fig. 6a). To evaluate whether HO-1 is neu-
roprotective after SCI, we injected A-C or A-HO-1 into
the spinal cord 7 days before SCI. Injected A-C induced
expression of EGFP (Additional file 1: Figure S4A) but
did not influence the expression of ATF4, NLRP1,
NLRP3, and NLRC4 in the spinal cord (Additional file 1:
Figure S4B), suggesting that AAV injection successfully
introduced exogenous genes into the spinal cord while
not altering endogenous inflammasome-related gene ex-
pression. A-C also did not significantly alter HO-1
Fig. 3 SCI induces HO-1 expression in the spinal cord. a HO-1 expression in injured spinal cords was determined by immunoblot at different time
points after SCI. 0: immediately after SCI. b Statistical analysis for HO-1 protein level in injured spinal cords after SCI. 0: immediately after SCI. c HO-1
expression in MAP2+ spinal cord neurons was indicated by immunofluorescent staining. N = 6 per group. *p < 0.05; ***p < 0.001 in comparison with
sham control
Lin et al. Journal of Neuroinflammation  (2016) 13:52 Page 7 of 14
Fig. 4 HO-1 protects spinal cord neurons from NLRP1 inflammasome-induced neuronal death. a H2O2 induced NLRP1 expression in primary spinal
cord neurons after 6-h treatment. Left panel: representative immunoblot image. Right panel: statistical analysis for inflammasome components. Un:
untreated control. b Association of NLRP1 with ASC and caspase-1 was determined by co-immunoprecipitation after 6-h H2O2 treatment. Un:
untreated control. c HO-1 inhibited NLRP1 expression after H2O2 treatment. Primary neurons were transduced with A-HO-1 or transfected with HO-1
siRNA. Twenty four hours later, neurons were treated with H2O2 for additional 6 h. Expression of HO-1 and NLRP1 was determined by immunoblot. This
is a representative image of four independent experiments. C: cells under transduction or transfection condition without AAV and siRNA. Si-HO-1: HO-1
siRNA. d Statistical analysis for the expression of HO-1 and NLRP1 in c. *p < 0.05; ***p < 0.001 compared with “C” group. e Expression of pro-caspase-1
and caspase-1 p20 in H2O2-treated primary neurons. Un: untreated control. C: cells under transduction or transfection condition without AAV and
siRNA. Si-HO-1: HO-1 siRNA. f Representative images of TUNEL staining after 12-h H2O2 treatment. Un: untreated control. C: cells under transduction or
transfection condition without AAV and siRNA. Si-HO-1: HO-1 siRNA. Si-NLRP1: NLRP1 siRNA. g Statistical analysis for TUNEL. N = 6 per group. *p < 0.05;
**p < 0.01; ***p < 0.001
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expression after SCI (Additional file 1: Figure S4C). A-
HO-1 significantly increased HO-1 level in the post-SCI
spinal cord in comparison with A-C (Fig. 6b). In
addition, A-HO-1 significantly reduced ATF4 and
NLRP1 expression after SCI compared with A-C but did
not change the expression of NLRP3 and NLRC4
(Fig. 6b). Consistent with lower NLRP1 level, the expres-
sion of caspase-1 p20 was down-regulated by A-HO-1
(Fig. 6c). Interestingly, the expression of pro-caspase-1
was also reduced by A-HO-1 (Fig. 6c), suggesting that
HO-1 might directly or indirectly inhibited caspase-1 ex-
pression in vivo. TUNEL revealed that A-HO-1 effect-
ively decreased neuronal death after SCI (Fig. 6d). To
assess the change of hindlimb locomotor function after
SCI, the BBB score at pre-injury and 1, 3, 7, 14, and
21 days after SCI are shown in Fig. 6e. All rats initially
showed a slight decrease in the BBB score, and there
was no significant difference among the four groups be-
fore SCI. The sham group showed full recovery 3 days
after SCI. The vehicle, A-C and A-HO-1 groups showed
a sharp decrease in the BBB score 1 day after SCI. Partial
improvements were observed, and there was no
significant difference among the vehicle and A-C group
after SCI. However, the neurological improvements were
significantly greater in the A-HO-1 group compared to
the improvements in the vehicle and A-C groups at 3, 7,
14, and 21 days after SCI.
Discussion
In this study, we examined the role of HO-1 in regulat-
ing NLRP1 inflammasome formation and neuronal death
after SCI. SCI consists of a primary mechanical injury
and a secondary inflammatory injury and apoptosis [1].
The primary injury is locally restricted to the area of
the vertebral fracture and is characterized by acute
hemorrhage and ischemia. The secondary injury is char-
acterized by further destruction of neurons and glial
cells and leads to significant expansion of the damage,
so that paralysis can extend to higher segments. After
SCI, cell death at the lesion site comprises both post-
traumatic necrosis and apoptosis [41]. A time course
analysis reveals that apoptosis occurs as early as 4 h post
injury and can be seen in decreasing amounts as late as
3 weeks after SCI [42]. Apoptosis was observed in both
Fig. 5 HO-1 inhibits NLRP1 expression through ATF4. a Expression of ATF4 and CHOP in primary neurons were determined by immunoblot after
6-h H2O2 treatment. Left panel: representative immunoblot image. Right panel: statistical analysis for the expression of ATF4 and CHOP. Un: untreated
control. N = 4 per group. ***p < 0.001 compared with “Un” group. b mRNA levels of ATF4 and NLRP1 in primary neurons. Primary neurons
were transfected with different doses of ATF4 siRNA 48 h before treatment with H2O2 for additional 6 h. N = 3 per group. *p < 0.05; **p < 0.01;
***p < 0.001 compared with “0” group. c Neurons were treated as in b, followed by detection of neuronal death with TUNEL after 12-h H2O2
treatment. N = 6 per group. *p < 0.05; ***p < 0.001 compared with “0” group. d Protein level of ATF4 in primary neurons. Primary neurons were
transduced with A-HO-1 or transfected with ATF4 siRNA for 24 h before treatment with H2O2 for additional 6 h. Un: untreated control. C: cells
under transduction or transfection condition without AAV and siRNA. Si-ATF4: siRNA for ATF4. This is a representative of three independent
experiments. e Neurons were treated as in d. mRNA level of ATF4 was determined by q-RTPCR. N = 5 per group. **p < 0.01; ***p < 0.001
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neurons and oligodendrocytes. Activation of caspase-3
or 9 occurs in neurons at the injury site within hours
and in neurons distant from the injury site over a period
of days. Although activation of caspase-3 or 9 contrib-
utes to neuronal death, neuronal death can also be
induced by caspase-1, which is activated directly via a
CARD-containing inflammasome. Therefore, successful
assembly and activation of inflammasomes are critical
for the initiation of neuronal death. Although inflamma-
somes are generally formed in inflammatory immune
cells, accumulating evidences have indicated that distinct
types of inflammasomes are also present in neurons.
NLRP1 inflammasomes mediate neuron injury under high
glucose [43]. High extracellular potassium opens pannexin
channels leading to inflammasome activation in primary
neurons and astrocytes [44]. Importantly, recent studies
Fig. 6 Administration of A-HO-1 protects neurons from SCI-induced neuronal death in vivo. a Expression of ATF4 and CHOP in injured spinal
cords after SCI. Left panel: representative immunoblot image. Right panel: statistical analysis for the expression of ATF4 and CHOP. 0: immediately
after SCI. N = 3 per group. *p < 0.05; ***p < 0.001 compared with “0” group. b Expression of HO-1, ATF4, and inflammasome components in injured
spinal cords 24 h after SCI. Left panel: representative immunoblot image. Right panel: statistical analysis for the expression of each protein. Sham:
sham control. N= 5 per group. **p< 0.01; ***p< 0.001 compared with sham control. #p< 0.05 compared with A-C group. c Expression of pro-caspase-1
and caspase-1 p20 in injured spinal cords 24 h after SCI. Left panel: representative immunoblot image. Right panel: statistical analysis for the expression of
each protein. Sham: sham control. N = 5 per group. d Neuronal death was quantified by TUNEL 24 h after SCI. e BBB score after SCI. N = 10
per group. *p < 0.05; **p < 0.01; ***p < 0.001
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have showed inflammasome formation in different neur-
onal disorders including SCI [12, 21, 38, 45].
Our study confirmed NLRP1 inflammasome formation
in the spinal cord neurons after SCI. Interestingly,
among the three NOD-like receptor proteins examined,
only NLRP1 level was elevated after SCI. However, an-
other study reported NLRP3 inflammasome formation
in a SCI model [46]. The main difference between our
model and their’s is the spinal segmental levels receiving
SCI: ours was spinal T12 and theirs was spinal T9. This
disparity raised an interesting question of whether SCI
performed on different spinal levels leads to activation
of different inflammasome types. However, to our know-
ledge, no previous or current studies indicated different
responses to insults/stimuli in different spinal segmental
neurons. Hence, further investigation will be needed to
elucidate the mechanism underlying this disparity.
In addition to elevated expression of NLRP1, ASC,
and caspase-1, the association of these proteins was
also up-regulated to form NLRP1 inflammasomes in
injured spinal cord. The molecular signaling which
triggers inflammasome assembly after SCI has been
previously studied. It has been proposed that danger
signals such as high plasma glucose, β-amyloid, Toll-
like receptor (TLR) ligands, uric acid, and ATP induce
inflammasome activation [47–51]. In particular, the
engagement of ATP with P2X4 or P2X7 purinergic
receptors induces inflammasome activation. Spinal cord
neurons express P2X7 purinergic receptors, and expos-
ure to ATP led to high-frequency spiking, irreversible
increases in cytosolic calcium, and cell death [52].
Systemic administration of an antagonist of P2X7 re-
ceptors improves recovery after SCI [53]. P2X4 recep-
tors are expressed in spinal cord neurons and are
responsible for inflammasome activation after SCI [45].
Importantly, SCI induces increase of ATP release in
peritraumatic areas [52]. Therefore, it is highly possible
that excessive ATP release activates these purinergic re-
ceptors to induce NLRP1 inflammasome formation.
Another possibility is that TLRs might induce post-SCI
NLRP1 inflammasome formation. Although TLRs are
generally considered to be expressed in microglia and
astrocytes, recent research has showed that TLR ex-
pression in neurons is pivotal under both physiological
and pathological conditions [54–57]. Perhaps SCI
changes expression of certain TLRs which recognize
danger signals after injury and subsequently causes
inflammasome formation. Further study will be per-
formed to test this hypothesis.
The induction of HO-1 after SCI is consistent with a
previous report [31]. However, the exact mechanisms
underlying this induction have not been completely
understood. Hemin could be one of the candidates
which induce HO-1 expression, since a study stated that
hemin induces HO-1 in spinal cord vasculature after
SCI [58]. It is possible that hemin is released from red
blood cells into the interstitial space as a result of
hemorrhage after SCI. Cultured cerebellar granular neu-
rons express heme carrier protein 1 (HCP1), and HCP1
contributes to the time- and concentration-dependent
accumulation of hemin in neurons, which causes sub-
stantial neurotoxicity [59]. However, to our knowledge,
there is no information about HCP1 expression in spinal
cord neurons. Thus, further study will be needed to in-
vestigate the effect of hemin on spinal cord neurons.
Other factors, such as hypoxia, reactive oxygen species,
and pro-inflammatory cytokines can also regulate HO-1
expression in different cell types [60]. Perhaps the post-
SCI HO-1 expression is a combined effect of above
factors rather than the effect of a single factor. Of note,
the HO-1 induction peaked at 18 h after SCI and was
decreased at 24 h with respect to 18 h. This dynamic
change of HO-1 expression might be explained by the
transcriptional repression through Bach1. Bach1 is a
transcriptional repressor of heme oxygenase-1 gene. A
similar decrease of HO-1 expression by Bach1 is ob-
served in rat fibroblasts and human lung cancer cells ex-
posed to cigarette smoke condensate in a previous study
[61]. In addition, genetic ablation of Bach1 leads to up-
regulation of HO-1 in myocardial ischemia/reperfusion
and SCI in mice [62, 63]. Moreover, HO-1 induction is
also associated with down-regulation of Bach1 in ische-
mic brains [64]. However, the kinetics of Bach1 expres-
sion after compressive SCI is not fully understood.
Interestingly, hypoxia-inducible factor-1 (HIF-1), which
is up-regulated in injured spinal cords [65], induces the
expression of Bach1 [66, 67]. Therefore, it is possible
that down-regulation of HO-1 at 24 h is due to up-
regulation of Bach1 by HIF-1. Future investigation will
be needed to verify this hypothesis.
The anti-inflammatory role of HO-1 has been reported
previously. Hemin-induced HO-1 inhibits NLRP3
inflammasome formation in acute lung injury [68]. In-
duction of HO-1 attenuates lipopolysaccharide-induced
inflammasome formation in human gingival epithelial
cells [69]. However, up-regulation of HO-1 is not always
anti-inflammatory. The HO activity may exert a different
effect on inflammation. Navarra et al. reported that HO
activation blunts the systemic response to stressors [70].
In addition, Barone et al. found that HO-1 demonstrates
increased serine residue phosphorylation and oxidative
post-translational modifications in hippocampus and
cerebellum in Alzheimer’s disease, suggesting HO-1 as a
target of oxidative damage even in the cerebellum [71].
This serine residue phosphorylation may influence the
HO-1 activity [72]. Therefore, elucidation of the exact
role of HO in the neuropathy including SCI needs more
elaborated research designs. In our study, HO-1 inhibits
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post-SCI NLRP1 expression via the transcription factor
ATF4, indicating HO-1 is likely anti-inflammatory in the
local SCI area. To our knowledge, we are the first to re-
port the role of HO-1 in regulating ATF4 expression.
Previous studies imply that ATF4 positively regulates
HO-1 expression [73, 74], but no evidence has shown
the effect of HO-1 on ATF4 expression. The mechanism
by which HO-1 down-regulates ATF4 is still unknown.
Based on the fact that cytosolic HO-1 is able to translo-
cate into the nuclei of certain tumor cells [75–77], it is
possible that HO-1 could directly act as a transcription
suppressor or indirectly regulate some transcription fac-
tors to inhibit ATF4 expression. It has been reported
that HO-1 modulates subcellular distribution and activa-
tion of Nrf2 [75], suggesting HO-1 is able to influence
the activity of certain transcription factors. However, in
our study, HO-1 seems to be located only in the cytosol,
excluding its effect in the nucleus. We speculated that
HO-1 might regulate ATF4 expression through other
mechanisms rather than acting as a transcription sup-
pressor. Our ongoing study is analyzing the downstream
molecules of HO-1 signaling in an effort to assess which
factor is responsible for this effect.
Inflammasome-associated neuronal death has been a
research interest both in basic and clinical studies. With
inflammasomes, pro-caspase-1 is activated. Its function
includes conversion of the pro-IL-1β and pro-IL-18 into
active IL-1β and IL-18. Cell membrane integrity is
destroyed as a result of micropore formation caused by
caspase-1, IL-1β, and IL-18. These micropores lead to a
series of processes such as cytoplasm release, cell os-
motic lysis, and inflammatory reaction. In addition,
Caspase-1 is involved in degradation of DNA and chro-
mosomes because a specific endonuclease is activated by
caspase-1. Caspase-1 also triggers degradation of cyto-
skeletal proteins. In our study, NLRP1 inflammasomes
were closely related to post-SCI neuronal death. How-
ever, it is still unclear which cell death type—apoptosis,
pyroptosis, or necrosis—is dominant in the acute phase
of SCI. It is plausible that each death type contributes to
neuronal death at a certain time period during and after
SCI, depending on the duration and severity of SCI. At
the beginning of SCI, the injury stress might directly
cause apoptosis or necrosis when inflammasomes have
not been activated. Later on, when less damaged neu-
rons and neurons in the penumbra are under inflamma-
tory stress, the pyroptosis could couple with apoptosis
to enhance the secondary injury. A recent study showed
that AIM2 and NLRP3 inflammasomes activate both
apoptotic and pyroptotic death pathways [78], making
the relationship between apoptosis and pyroptosis more
complicated. An elaborated study on the post-SCI cell
death types will be needed to elucidate the neuronal
death processes during and after SCI.
Consistent with the anti-inflammatory effect of HO-1
in most cases [22, 79, 80], our study found that HO-1 in-
hibits inflammasome-induced neuronal death. Whether
HO-1 has the similar or different efficacy in other neur-
onal disorders such as ischemic stroke, Alzheimer’s dis-
ease, and multiple sclerosis needs further investigation.
Our study demonstrates a new mechanism by which
HO-1 protects neurons from SCI and might provide
new therapeutic clues for treating SCI.
Conclusions
NLRP1 inflammasomes were assembled and activated in
neurons after spinal cord injury (SCI). HO-1 expression
was induced in spinal cord neurons in association with
the formation of NLRP1 inflammasomes. Administration
of HO-1-expressing adeno-associated virus into spinal
cords before SCI effectively decreased SCI-induced
NLRP1 inflammasome formation, alleviated neuronal
death, and improved functional recovery. HO-1 down-
regulates NLRP1 expression through inhibiting expres-
sion of ATF4. Our study demonstrates a new mechanism
by which HO-1 protects neurons from SCI.
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